ORLANDO, Fla., Sept. 05, 2025 (GLOBE NEWSWIRE) -- Abacus Global Management, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a leader in the alternative asset management space, today announced its participation in two upcoming investor conferences in September 2025. The Company will attend the B. Riley Securities 8th Annual Consumer & TMT Conference on September 10, 2025, at the Sofitel New York in New York City. Chief Operating Officer Elena Plesco and Senior Vice President of Investor Relations and Corpora ...

Motion underscores that Abacus's claims lack merit as Lapetus, its key life expectancy provider, shut its doors August 31FORT WASHINGTON, Pa., Sept. 2, 2025 /PRNewswire/ -- Coventry First LLC ("Coventry") and its Co-Founder and Executive Chairman, Alan H. Buerger, today announced that they have filed a Motion to Dismiss the complaint brought by Abacus Global Management, Inc. ("Abacus") (NASDAQ: ABL) in the U.S. District Court for the Middle District of Florida on August 29, 2025. The full Complaint can be f ...

Core Viewpoint - Pomerantz LLP is investigating claims of potential securities fraud and unlawful business practices involving Abacus Global Management, Inc. [1] Group 1: Investigation Details - The investigation is focused on whether Abacus and its officers or directors have engaged in fraudulent activities [1] - Investors are encouraged to contact Pomerantz LLP for more information regarding the investigation [1] Group 2: Allegations Against Abacus - A report by Morpheus Research claims that Abacus has manipulated its portfolio valuation methodology to present a misleadingly profitable image [3] - The report also criticizes Abacus's life expectancy estimation methods and highlights historical concerns regarding its co-founders [3] Group 3: Market Reaction - Following the release of the allegations, Abacus's stock price dropped by $1.64, or 21.47%, closing at $6.00 per share on June 5, 2025 [4]

Core Viewpoint - Pomerantz LLP is investigating claims of potential securities fraud and unlawful business practices by Abacus Global Management, Inc. [1] Group 1: Investigation Details - The investigation is focused on whether Abacus and its officers or directors have engaged in fraudulent activities [1] - A report by Morpheus Research alleges that Abacus has manipulated its portfolio valuation methodology to present a misleadingly profitable image [2] - The report also raises concerns about Abacus's life expectancy estimation methods and highlights historical issues related to its co-founders [2] Group 2: Market Reaction - Following the news of the investigation and the report, Abacus's stock price dropped by $1.64 per share, representing a 21.47% decline, closing at $6.00 per share on June 5, 2025 [3]

Company Overview - Proactive is a financial news publisher that provides fast, accessible, informative, and actionable business and finance news content to a global investment audience [2] - The company has a team of experienced news journalists who produce independent content across various financial markets [2] Market Focus - Proactive specializes in medium and small-cap markets while also covering blue-chip companies, commodities, and broader investment stories [3] - The content delivered includes insights across sectors such as biotech and pharma, mining and natural resources, battery metals, oil and gas, crypto, and emerging digital and EV technologies [3] Technology Adoption - Proactive is recognized for its forward-looking approach and enthusiastic adoption of technology to enhance workflows [4] - The company utilizes automation and software tools, including generative AI, while ensuring that all content is edited and authored by humans [5]

Core Viewpoint - Abacus Global Management, Inc. is under investigation for potential violations of federal securities laws and unlawful business practices, following a significant drop in stock price after a critical report [1][2]. Group 1: Company Overview - Abacus Global Management, Inc. is a publicly traded company listed on NASDAQ under the ticker ABL [1]. - The company has been associated with a SPAC valued at $740 million [2]. Group 2: Legal Investigation - Bragar Eagel & Squire, P.C. is investigating claims on behalf of Abacus stockholders regarding possible legal violations [1]. - The investigation was prompted by a report from Morpheus Research that accused Abacus of engaging in accounting schemes to inflate revenue [2]. Group 3: Stock Performance - Following the publication of the critical report on June 4, 2025, Abacus's stock price experienced a decline of over 21% [2].

PART I. FINANCIAL INFORMATION [Financial Statements](index=4&type=section&id=Item%201.%20Financial%20Statements) Unaudited H1 2025 financial statements show total assets decreased to $848.4 million, while revenues surged to $100.4 million and net income reached $23.0 million [Consolidated Balance Sheets](index=4&type=section&id=Consolidated%20Balance%20Sheets) As of June 30, 2025, total assets decreased to $848.4 million, primarily due to a drop in cash, while total liabilities also decreased to $426.8 million Consolidated Balance Sheet Summary ($ Thousands) | Balance Sheet Item | June 30, 2025 (unaudited) | December 31, 2024 | | :--- | :--- | :--- | | **Assets** | | | | Cash and cash equivalents | $74,837 | $131,944 | | Life settlement policies, at fair value | $386,145 | $370,398 | | Goodwill | $238,921 | $238,296 | | **Total Assets** | **$848,358** | **$874,165** | | **Liabilities & Equity** | | | | Current portion of long-term debt, at fair value | $117,870 | $37,430 | | Long-term debt, net | $224,896 | $224,742 | | **Total Liabilities** | **$426,825** | **$450,870** | | **Total Stockholders' Equity** | **$416,533** | **$423,295** | - Cash and cash equivalents decreased by **$57.1 million**, from **$131.9 million** at the end of 2024 to **$74.8 million** as of June 30, 2025[5](index=5&type=chunk) - The current portion of long-term debt measured at fair value increased significantly to **$117.9 million** from **$37.4 million**, reflecting upcoming maturities, including the LMAIS II redemption window opening in March 2026[5](index=5&type=chunk)[33](index=33&type=chunk) [Consolidated Statements of Operations](index=6&type=section&id=Unaudited%20Consolidated%20Statements%20of%20Operations%20and%20Comprehensive%20Income%20%28Loss%29) Q2 2025 total revenues surged to $56.2 million, driving net income to $17.6 million, while H1 2025 revenues doubled to $100.4 million, resulting in $23.0 million net income Key Performance Indicators (Q2 2025 vs Q2 2024, $M) | Metric | Q2 2025 | Q2 2024 | Change | | :--- | :--- | :--- | :--- | | Total Revenues | $56.2 | $29.1 | +93.4% | | Gross Profit | $50.2 | $26.3 | +90.8% | | Operating Income | $22.5 | $6.8 | +232.3% | | Net Income | $17.6 | $0.7 | +2414.3% | | Diluted EPS | $0.18 | $0.01 | +1700% | Key Performance Indicators (Six Months Ended June 30, $M) | Metric | H1 2025 | H1 2024 | Change | | :--- | :--- | :--- | :--- | | Total Revenues | $100.4 | $50.6 | +98.4% | | Gross Profit | $87.2 | $45.1 | +93.4% | | Operating Income | $43.5 | $9.0 | +383.3% | | Net Income (Loss) | $23.0 | ($0.6) | NM | | Diluted EPS | $0.23 | ($0.01) | NM | [Consolidated Statements of Mezzanine Equity and Stockholders' Equity](index=8&type=section&id=Unaudited%20Consolidated%20Statements%20of%20Mezzanine%20Equity%20and%20Stockholders%27%20Equity) During H1 2025, total stockholders' equity decreased to $416.5 million due to common stock repurchases, partially offset by net income and preferred stock issuance - The company repurchased **5,081,477 shares** of common stock for **$35.1 million** during the second quarter of 2025[10](index=10&type=chunk) - Issued **5,000 shares** of Series A Convertible Preferred Stock for **$5.0 million**, classified as mezzanine equity[10](index=10&type=chunk) - Net income attributable to the company of **$22.2 million** for the six months ended June 30, 2025, increased retained earnings (reduced accumulated deficit)[8](index=8&type=chunk)[10](index=10&type=chunk) [Consolidated Statements of Cash Flows](index=10&type=section&id=Unaudited%20Consolidated%20Statements%20of%20Cash%20Flows) For H1 2025, net cash provided by operating activities was $14.5 million, a significant improvement from the prior year, while financing activities used $57.9 million, resulting in a net cash decrease of $57.1 million Cash Flow Summary (Six Months Ended June 30, $M) | Cash Flow Activity | 2025 | 2024 | | :--- | :--- | :--- | | Net cash from Operating Activities | $14.5 | ($64.5) | | Net cash from Investing Activities | ($13.7) | ($0.7) | | Net cash from Financing Activities | ($57.9) | $131.0 | | **Net Change in Cash** | **($57.1)** | **$65.7** | - Financing activities in H1 2025 included **$35.1 million** for common stock repurchases and a net debt repayment of **$21.9 million**, contrasting with **$92.0 million** raised from a common stock sale in H1 2024[15](index=15&type=chunk) [Condensed Notes to Consolidated Financial Statements](index=12&type=section&id=Condensed%20Notes%20to%20Consolidated%20Financial%20Statements) The notes detail significant accounting policies, recent business combinations like the NIB acquisition, revenue disaggregation, and segment reporting changes, including a subsequent warrant exchange offer - On April 24, 2025, the Company acquired National Insurance Brokerage, LLC ("NIB") for approximately **$2.1 million** in cash, recognizing **$0.7 million** in goodwill assigned to the Life Solutions segment[49](index=49&type=chunk)[51](index=51&type=chunk) - In Q1 2025, the company updated its structure to three reportable segments: Asset Management, Life Solutions, and Technology Services, reflecting how management now reviews the business[81](index=81&type=chunk) - Subsequent to the quarter end, on June 30, 2025, the company commenced an exchange offer to redeem all outstanding Public and Private Placement Warrants for common stock[181](index=181&type=chunk) [Management's Discussion and Analysis of Financial Condition and Results of Operations](index=52&type=section&id=Item%202.%20Management%27s%20Discussion%20and%20Analysis%20of%20Financial%20Condition%20and%20Results%20of%20Operations) Management attributes significant H1 2025 revenue and profit growth to successful acquisitions and strong segment performance, with Q2 Adjusted EBITDA reaching $31.5 million and sufficient liquidity [Results of Operations](index=52&type=section&id=Results%20of%20Operations) For Q2 2025, total revenue increased 93.4% to $56.2 million, driven by surges in Asset Management and Life Solutions revenue, leading to a 232% increase in operating income to $22.5 million - Asset management revenue for Q2 2025 increased by **$8.6 million**, or **4176.4%**, primarily due to the Carlisle and FCF acquisitions completed in December 2024[189](index=189&type=chunk) - Life solutions revenue for Q2 2025 grew by **$18.4 million**, or **63.8%**, mainly from a **$49.6 million** increase in realized gains from life policies, partially offset by changes in unrealized gains and premiums paid[191](index=191&type=chunk) - General and administrative expenses for Q2 2025 increased by **$4.4 million** (**30.0%**), driven by higher legal/professional fees and payroll related to acquisitions, though partially offset by lower stock-based compensation expense[203](index=203&type=chunk) [Segment Results](index=62&type=section&id=Results%20of%20Operations%E2%80%94Segment%20Results) For Q2 2025, Asset Management gross profit skyrocketed due to acquisitions, Life Solutions gross profit increased 70.3%, while the new Technology Services segment reported a gross loss Segment Gross Profit (Q2 2025 vs Q2 2024) | Segment | Q2 2025 Gross Profit | Q2 2024 Gross Profit | Change | | :--- | :--- | :--- | :--- | | Asset Management | $5,714,783 | $36,217 | +15679.3% | | Life Solutions | $44,790,299 | $26,296,351 | +70.3% | | Technology Services | ($335,106) | $0 | NM | [Non-GAAP Financial Measures and Key Business Metrics](index=64&type=section&id=Non-GAAP%20Financial%20Measures%20and%20Key%20Business%20Metrics) The company reported Q2 2025 non-GAAP Adjusted Net Income of $21.9 million and Adjusted EBITDA of $31.5 million, driven by a 303% increase in life policies sold and Assets Under Management reaching $2.87 billion Non-GAAP Reconciliation Summary (Q2 2025 vs Q2 2024, $M) | Metric | Q2 2025 | Q2 2024 | | :--- | :--- | :--- | | Net Income Attributable to Co. | $17.6 | $0.8 | | Adjusted Net Income | $21.9 | $11.7 | | Adjusted EPS - Diluted | $0.22 | $0.17 | | Adjusted EBITDA | $31.5 | $16.7 | - The number of life policies sold under the fair value method increased dramatically to **399** in Q2 2025 from **99** in Q2 2024, a **303%** increase[261](index=261&type=chunk) - As of June 30, 2025, Assets Under Management (AUM) reached **$2.87 billion**, a key driver for the Asset Management segment[264](index=264&type=chunk) [Liquidity and Capital Resources](index=77&type=section&id=Liquidity%20and%20Capital%20Resources) As of June 30, 2025, the company had $74.8 million in cash and cash equivalents, with management believing current liquidity is sufficient for the next 12 months, following $35.1 million in stock repurchases during H1 2025 - The company's principal source of liquidity as of June 30, 2025, was cash and cash equivalents of **$74.8 million**[267](index=267&type=chunk) - The Board of Directors has authorized stock repurchase plans totaling **$50 million**, with **$2.9 million** remaining available for repurchases as of June 30, 2025[269](index=269&type=chunk) [Quantitative and Qualitative Disclosures About Market Risk](index=80&type=section&id=Item%203.%20Quantitative%20and%20Qualitative%20Disclosures%20About%20Market%20Risk) The company is a smaller reporting company and is not required to provide the information for this item - As a smaller reporting company, Abacus is exempt from providing quantitative and qualitative disclosures about market risk[280](index=280&type=chunk) [Controls and Procedures](index=80&type=section&id=Item%204.%20Controls%20and%20Procedures) Management, including the CEO and CFO, concluded that the company's disclosure controls and procedures were effective as of June 30, 2025, with no material changes to internal control over financial reporting during the quarter - The principal executive officer and principal financial officer concluded that the company's disclosure controls and procedures were effective as of the end of the quarter[281](index=281&type=chunk) - No material changes were identified in the company's internal control over financial reporting during the three months ended June 30, 2025[282](index=282&type=chunk) PART II. OTHER INFORMATION [Legal Proceedings](index=81&type=section&id=Item%201.%20Legal%20Proceedings) The company is not a party to any litigation that would be considered material to its ongoing operations as of June 30, 2025 - As of the period ended June 30, 2025, the Company is not involved in any material legal proceedings[283](index=283&type=chunk) [Risk Factors](index=81&type=section&id=Item%201A.%20Risk%20Factors) There have been no material changes to the risk factors previously disclosed in the company's 2024 Annual Report on Form 10-K - No material changes to the risk factors disclosed in the 2024 Annual Report on Form 10-K have occurred as of the date of this report[284](index=284&type=chunk) [Unregistered Sales of Equity Securities and Use of Proceeds](index=81&type=section&id=Item%202.%20Unregistered%20Sales%20of%20Equity%20Securities%20and%20Use%20of%20Proceeds) This section refers to Note 15 of the financial statements for details regarding the company's stock repurchase program and activities during the first six months of 2025 - Information regarding the company's stock repurchase program and shares repurchased during the period is detailed in Note 15 of the financial statements[285](index=285&type=chunk) [Other Information](index=81&type=section&id=Item%205.%20Other%20Information) During the second quarter of 2025, no company officers or directors adopted or terminated any Rule 10b5-1 trading arrangements or non-Rule 10b5-1 trading arrangements - No officers or directors adopted or terminated any Rule 10b5-1 or non-Rule 10b5-1 trading arrangements during the quarter ended June 30, 2025[286](index=286&type=chunk)

Core Viewpoint - Abacus Global Management has made a minority investment in Dynasty Financial Partners, highlighting a strategic partnership aimed at enhancing service offerings and expanding market presence in the wealth management sector [2][3][4]. Company Overview - Abacus Global Management specializes in alternative asset management, data-driven wealth solutions, and technology innovations, focusing on longevity-based assets and personalized financial planning [4]. - Dynasty Financial Partners provides technology-enabled wealth management solutions for independent financial advisory firms, primarily targeting high net worth and ultra-high net worth clients [5][6]. Investment Details - The investment by Abacus is seen as a continuation of a long-term strategic relationship with Dynasty, which has 57 Network Partner firms and manages over $105 billion in platform assets [3][4]. - The partnership is expected to support both companies' growth plans and enhance their service capabilities in the independent wealth management space [4][6]. Industry Context - The independent wealth management sector has experienced significant growth, with increasing opportunities for firms that leverage technology and provide comprehensive services [4][6]. - Dynasty has played a pivotal role in shifting assets from traditional brokerage channels to independent wealth management, emphasizing the benefits of independence for advisory firms [6].

[FORM 8-K Filing Information](index=1&type=section&id=FORM%208-K%20Filing%20Information) This section provides essential identification details for the Form 8-K filing, covering registrant information and registered securities [Registrant and Filing Details](index=1&type=section&id=Registrant%20and%20Filing%20Details) This section provides the basic identification details for the Form 8-K filing, including the registrant's name, jurisdiction, SEC file number, and principal executive offices - Registrant: Abacus Global Management, Inc., incorporated in Delaware[1](index=1&type=chunk) Registered Securities on NASDAQ Capital Market LLC | Title of each class | Trading Symbols | Name of each exchange on which registered | | :------------------ | :-------------- | :---------------------------------------- | | Common stock, par value $0.0001 per share | ABL | The NASDAQ Capital Market LLC | | 9.875% Fixed Rate Senior Notes due 2028 | ABLLL | The NASDAQ Capital Market LLC | [Item 2.02 Results of Operations and Financial Condition](index=1&type=section&id=Item%202.02%20Results%20of%20Operations%20and%20Financial%20Condition) This section details the announcement of Q2 2025 financial results and the company's emerging growth status [Announcement of Financial Results](index=1&type=section&id=Announcement%20of%20Financial%20Results) Abacus Global Management, Inc. announced its operational results and financial condition for the quarterly period ended June 30, 2025, on August 7, 2025 - Abacus announced **Q2 2025 financial results** on August 7, 2025[3](index=3&type=chunk) - The press release (Exhibit 99.1) is furnished and incorporated by reference, but not deemed 'filed' with the SEC for certain purposes[3](index=3&type=chunk)[4](index=4&type=chunk) [Emerging Growth Company Status](index=1&type=section&id=Emerging%20Growth%20Company%20Status) The company has indicated its status as an 'emerging growth company' and has elected not to use the extended transition period for complying with new or revised financial accounting standards - Abacus Global Management, Inc. is an **'emerging growth company'**[3](index=3&type=chunk) - The company elected not to use the extended transition period for new or revised financial accounting standards[3](index=3&type=chunk) [Item 9.01 Financial Statement and Exhibits](index=2&type=section&id=Item%209.01%20Financial%20Statement%20and%20Exhibits) This section lists all financial statements and exhibits furnished with the Form 8-K filing [List of Exhibits](index=2&type=section&id=List%20of%20Exhibits) This section lists the exhibits furnished with the Form 8-K, primarily the press release announcing the financial results and the interactive data file Form 8-K Exhibits | Exhibit Number | Exhibit Description | | :------------- | :---------------------------------------------------------------- | | 99.1 | Press Release dated August 7, 2025 announcing financial results for the quarter ended June 30, 2025 | | 104 | Cover Page Interactive Data File (formatted as inline XBRL) | [Legal Disclosures and Signatures](index=2&type=section&id=Legal%20Disclosures%20and%20Signatures) This section covers standard legal disclosures for forward-looking statements and the official report signing [Forward-Looking Statements](index=2&type=section&id=Forward-Looking%20Statements) This standard disclosure warns that the report and furnished materials contain forward-looking statements subject to risks and uncertainties, which could cause actual events or results to differ materially - The report contains forward-looking statements, identified by words such as 'expect,' 'plan,' and 'anticipate'[7](index=7&type=chunk) - These statements are based on management's current expectations and subject to risks detailed in other SEC filings (Form 10-K, Form 10-Q)[7](index=7&type=chunk) - Abacus explicitly disclaims any obligation to update forward-looking statements, except as legally required[7](index=7&type=chunk) [Signatures](index=3&type=section&id=Signatures) The report was duly signed on behalf of Abacus Global Management, Inc. by its Chief Executive Officer, Jay Jackson, on August 8, 2025 - The report was signed by **Jay Jackson**, Chief Executive Officer of Abacus Global Management, Inc.[9](index=9&type=chunk) - Date of signature: **August 8, 2025**[9](index=9&type=chunk)

Group 1: Earnings Performance - Abacus Life, Inc. reported quarterly earnings of $0.22 per share, exceeding the Zacks Consensus Estimate of $0.16 per share, and up from $0.18 per share a year ago, representing an earnings surprise of +37.50% [1] - The company has surpassed consensus EPS estimates for four consecutive quarters [2] - The revenue for the quarter ended June 2025 was $56.23 million, surpassing the Zacks Consensus Estimate by 33.05%, compared to $29.08 million in the same quarter last year [2] Group 2: Stock Performance and Outlook - Abacus Life, Inc. shares have declined approximately 29.1% since the beginning of the year, while the S&P 500 has gained 7.9% [3] - The current consensus EPS estimate for the upcoming quarter is $0.20 on revenues of $48.5 million, and for the current fiscal year, it is $0.76 on revenues of $188.21 million [7] - The estimate revisions trend for Abacus Life, Inc. was unfavorable prior to the earnings release, resulting in a Zacks Rank 4 (Sell) for the stock, indicating expected underperformance in the near future [6] Group 3: Industry Context - The Insurance - Life Insurance industry, to which Abacus Life, Inc. belongs, is currently in the top 20% of over 250 Zacks industries, suggesting a favorable industry outlook [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5]